Advertisement
U.S. Markets closed

Enliven Therapeutics, Inc. (ELVN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
29.00+0.98 (+3.50%)
At close: 04:00PM EDT
29.00 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.37B
Enterprise Value 1.06B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.49
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -6.28

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 330.01
52 Week Low 39.80
50-Day Moving Average 323.92
200-Day Moving Average 320.42

Share Statistics

Avg Vol (3 month) 3236.9k
Avg Vol (10 day) 3238.46k
Shares Outstanding 547.24M
Implied Shares Outstanding 6N/A
Float 824.98M
% Held by Insiders 16.61%
% Held by Institutions 1102.99%
Shares Short (Sep 30, 2024) 46.1M
Short Ratio (Sep 30, 2024) 426.76
Short % of Float (Sep 30, 2024) 431.97%
Short % of Shares Outstanding (Sep 30, 2024) 412.92%
Shares Short (prior month Aug 30, 2024) 45.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.55%
Return on Equity (ttm)-28.37%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -95.95M
Net Income Avi to Common (ttm)-82.83M
Diluted EPS (ttm)-1.91
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)312.39M
Total Cash Per Share (mrq)6.61
Total Debt (mrq)169k
Total Debt/Equity (mrq)0.05
Current Ratio (mrq)14.39
Book Value Per Share (mrq)6.46

Cash Flow Statement

Operating Cash Flow (ttm)-72.17M
Levered Free Cash Flow (ttm)-31.1M